04 November 2013
Med Sci Monit 2013; 19:927-933
BACKGROUND: The aim of this study was to evaluate long-term efficacy, safety, stability, and predictability of photorefractive keratectomy (PRK) as treatment of astigmatism.
MATERIAL AND METHODS: Ninety-four eyes of 52 patients, treated with PRK for compound myopic astigmatism, compound hyperopic astigmatism, and mixed astigmatism were studied during a 36-month period. Main outcome measures were uncorrected and best-corrected visual acuity (UCVA, BCVA), refraction, and corneal transparency. Astigmatism correction was analyzed by a power vector method.
RESULTS: In myopic astigmatism group (42 eyes), postoperative UCVA was 20/40 or better in 100% of eyes, 20/25 or better in 38 eyes out of 42 (90.5%), and 20/20 or better in 25/42 eyes (59.5%). No eye lost lines of the BCVA, 40/42 (95.2%) eyes had refraction within ±1D and 37/42 (88.1%) within ±0.50 D. In the hyperopic astigmatism group (28 eyes), the UCVA was 20/40 or better in 100% of eyes, 20/25 or better in 26/28 eyes (92.8%), and 20/20 or better in 24/28 eyes (85.7%); 1/28 eyes (3.6%) lost 1 line of the BCVA, 23/28 eyes (82.1%) were within ±1D, and 21/28 (75%) were within ±0.50D. In the mixed astigmatism group (24 eyes), the UCVA was 20/40 or better in 100% of eyes, 20/25 or better in 22/24 eyes (91.7%) and 20/20 in 15/24 (62.5%) eyes. No eye lost lines of BCVA, 23/24 eyes (95.8%) were within 1.0 D, and 20/24 eyes (83.3%) were within 0.50 D of defocus refraction. Power vector analysis showed a significant reduction of blurring strength in all examined groups.
CONCLUSIONS: PRK is a safe and effective procedure for correction of all types of astigmatism, with good stability and efficacy at 3-year follow-up.
Keywords: Follow-Up Studies, Astigmatism - surgery, Lasers, Excimer - therapeutic use, Photorefractive Keratectomy - trends, Visual Acuity - physiology
27 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic Monoclonal Antibody for Advanced Non-Small Cell Lung Cancer (NSCLC)
Med Sci Monit 2021; 27:e934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
09 July 2021 : Database AnalysisA Simple Clinical Prediction Tool for COVID-19 in Primary Care with Epidemiology: Temperature-Leukocytes-CT...
Med Sci Monit In Press; DOI: 10.12659/MSM.931467
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
Most Viewed Current Articles
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700